In Silico Clinical Trials Market Size Worth $5.1 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, Feb. 24, 2022 /PRNewswire/ -- The global in silico clinical trials market size is expected to reach USD 5.1 billion by 2030 and is projected to expand at a CAGR of 7.4% over the forecast period, according to a new report by Grand View Research, Inc. Traditional clinical trials require huge expenditure to conduct research. Moreover, a high number of drugs and medical devices fail in the clinical trial owing to the lack of safety and efficacy, which creates huge losses for the clinical trial sponsors. These factors promote the demand for in silico clinical trials, to understand the behavior of drugs or medical devices in humans. In silico clinical trials use simulation techniques to understand the efficacy and safety of a drug or medical device.

This reduces the chances of adverse reactions, thus, improving the safety and efficacy of research studies. The market players are making significant investments to provide new treatments to the people. For instance, in June 2021, In silico Medicine raised USD 255 million in funding to boost its R&D for drug discovery, through in silico studies. The demand for in silico clinical trials was also improved during the pandemic as there was a temporary shutdown of clinical research sites and several studies for vaccines and therapeutic agents for COVID-19 were performed through in silico research models. Such actions are likely to have a positive impact on market growth.

Key Insights & Findings from the report:

• The medical device segment dominated the market in 2021 owing to the fact that the majority of in silico trials are performed for medical devices globally.
• The phase II segment accounted for the largest market revenue share in 2021.
• The oncology therapeutic area segment accounted for the largest market revenue share in 2021.
• The cancer clinical trials have high chances of incurring adverse effects on patients, which promotes the demand for in silico trials for cancer.
• North America held the largest revenue share in 2021 due to the presence of several global players operating in the market.
• In addition, a significant number of in silico trials are performed in the U.S., which further contributes to the growth of the regional market.

Read 180-page market research report, "In Silico Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology, Infectious Diseases), By Phase (Phase I, II, III), By Industry (Medical Devices, Pharmaceutical), And Segment Forecasts, 2022 - 2030", published by Grand View Research.

In Silico Clinical Trials Market Segmentation

Grand View Research has segmented the global in silico clinical trials market on the basis of industry, therapeutic area, phase, and region:

In Silico Clinical Trials Industry Outlook (Revenue, USD Million, 2018 - 2030)

• Medical Devices
• Pharmaceutical

In Silico Clinical Trials Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Infectious Disease
• Hematology
• Cardiology
• Dermatology
• Neurology
• Diabetes
• Others

In Silico Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

In Silico Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Spain
• Italy
• Asia Pacific
• India
• China
• Japan
• South Korea
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

List of Key Players of In Silico Clinical Trials Market

• Certara, Inc.
• Novadiscovery Sas
• Insilico Medicine, Inc.
• Dassault Systemes SE
• GNS Healthcare Inc.
• The AnyLogic Company
• InSilicoTrials
• Immunetrics Inc.
• Nuventra Pharma Sciences
• Abzena Ltd.

Check out more related studies published by Grand View Research:

• COVID-19 Clinical Trials Market - The global COVID-19 clinical trials market size is expected to reach USD 9.9 billion by 2027, registering a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. An increasing number of deaths due to coronavirus is creating a need to develop effective treatments, thereby boosting the market growth.
• Clinical Trials Management System (CTMS) Market - The global clinical trials management system (CTMS) market size is expected to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 12.1% over the forecast period. Rapid growth of healthcare IT, high R&D expenditure by life science and clinical research organizations, and adoption of CTMS solutions is anticipated to drive the market growth.
• Virtual Clinical Trials Market - The global virtual clinical trials market size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Grand View Pipeline
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg